A prospective trial of adjuvant therapy for high-risk uveal melanoma: assessing 5-year survival outcomes

Overview of attention for article published in British Journal of Ophthalmology, August 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (83rd percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

twitter: 8 X users
facebook: 1 Facebook page

guideline: 2 clinical guideline sources

Readers on

mendeley: 36 Mendeley

So far, Altmetric has seen 13 X posts from 8 X users, with an upper bound of 21,143 followers.

A prospective trial of adjuvant therapy for high-risk uveal #melanoma: assessing 5-year survival outcomes @BMJ_Ophth https://t.co/65m4JvZnYM

RT @ProfOculista: A prospective trial of adjuvant therapy for high-risk uveal #melanoma: assessing 5-year survival outcomes @BMJ_Ophth http…

A prospective trial of adjuvant therapy for high-risk uveal #melanoma: assessing 5-year survival outcomes @BMJ_Ophth https://t.co/65m4JvZnYM

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 9 additional X posts.